chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am not clear of connection to vaccine but on 1/7/22 I experienced a sudden pain in my chest which radiated to my left shoulder, neck and back.  This lasted approximately 30 minutes.  At the same time as the sudden pain, I felt tingling in my hands and feet.  I was a passenger in the car at the time and did not seek immediate medical care.  Four and five days after this event, I had similar pain following exercise but not as strong and for a shorter duration.  I did get in to see my primary care physician to follow up and was rereferred for blood work to test for Troponin and D-Dimer as well as a CCTA scan.  My blood pressure was above my normal low numbers during testing.  With continued chest pain, racing heart and no results from blood test or an appointment for the CCTA scan, I was concerned enough to go to the ER.  Blood Pressure was high, chest X-ray was normal, EKG was normal. Troponin and D-Dimer were normal.  A CT scan of the lungs was also normal.  Follow up testing with Cardiologists and CCTA scan have not revealed a heart concern to date.  Hypertension was diagnosed.  No real understanding of what caused event or ongoing chest pain.
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 19-JUN-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R024906 with expiration date 30-AUG-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010373:
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On 31 July 1989, 5 September 1989 and September 1995 the subject received 1st dose, 2nd dose and 3rd dose of ENGERIX B (20 mcg, unknown route and site), and experienced not responding to therapy and drug dose administration interval too long. The 3rd dose of ENGERIX B was administered more than the recommended 6 months after the series was started. The healthcare professional reported that lab tests were performed recently which showed a non-reactive level of HBcAb IgM. No further details were provided.
This spontaneous report was received from a 72 years old female patient concerning to her. The patient's medical history included low thyroid. On 17-JUL-2012, the patient was vaccinated with ZOSTAVAX about 3 inches from her armpit on the underside of her left arm (dose, route and lot not reported0. No other co-suspects were reported. Concomitant medication included "thyroid medication". On 17-JUL-2012, the patient had experienced swelling and redness at the injection site. The area of reaction varies in size from the size of a quarter to the size of a penny. No treatment information was reported. The patient had not recovered from the events. The relatedness for the events was unknown for ZOSTAVAX. Additional information is not expected.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received SHINGRIX for prophylaxis. On 21st July 2018 02:45, the patient received the 1st dose of SHINGRIX. On 21st July 2018, less than a day after receiving SHINGRIX, the patient experienced headache, joint pain, injection site pain, malaise, injection site swelling, injection site erythema, appetite lost and blotchy. The patient was treated with analgesic, nos. On an unknown date, the outcome of the headache, joint pain, injection site pain, malaise, injection site swelling, injection site erythema, appetite lost and blotchy were not recovered/not resolved. It was unknown if the reporter considered the headache, joint pain, injection site pain, malaise, injection site swelling, injection site erythema, appetite lost and blotchy to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received SHINGRIX on the left arm. The patient said she had an area of skin around the injection site that was red, swollen and blotchy. The area was very painful and the patient had been taking medication to help with the pain. The patient was taking the doses of the medication every six hours. The patient stated that she did not feel like eating since the injection.
Beginning 12/25/09 student c/o things going "too fast and being too loud", had fever at time, has had several of these incidents since then. Most recent today at school 1/7/10 - parents were told by MD that it could be a reaction to H1N1 vac on the 21st of December.
sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 17May2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 19May2021, outcome "not recovered", described as "sore throat".  Additional information: Caller states she had the Pfizer covid vaccine on Monday and began having a sore throat on Wednesday, Thursday, and Friday, which is today. Caller is asking if this is a normal side effect of vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
First Covid Injection, just a little arm pain, but a week later ringing in the ear and Shshshshshsh sound.   The 2nd Shot I had a fever after 24 hours and the ringing noises increased, which prompted me to seek medical help.  I had no quick access to a doctor so I pursued online help, where he prescribed the PREDNISONE 20 MG TAB.  A steroid.  It's still the same, no change.
Ten minutes post vax, the pt began to feel funny. Her upper left arm at the deltoid muscle for approximately 6 inches around the injection site was red, raised and appeared inflamed. Twenty minutes post vax, breathing felt tight and difficult. The pt received epinephrine IM in the right arm. About five minutes later BP was 184/110 with pulse of 64. Five minutes later breathing was back to normal, but the pt was having sharp chest and head pain and was trembling. Pt was transported to the ER where she spent less than two hours. She had experienced an anaphylactic reaction. The pt subsequently saw her physician who indicated that he does not wish her to have any more doses of Engerix B. A hepatitis B titer is planned in 2 months to check immunity. She has been advised to carry an Epi-Pen for any possible future medication reactions.
This spontaneous report was received from a pharmacist, concerning a 67 year old patient of unknown gender. The patient's medical history, concurrent conditions and drug reactions/ allergies were not reported. On 04-MAR-2016, the patient was vaccinated intramuscularly with a dose of ZOSTAVAX in the right upper deltoid muscle (lot # reported as L036823 with expiration date 24-DEC-2016). After the pharmacist realized her error, she administered on the same day, on 04-MAR-2016, another dose of ZOSTAVAX by subcutaneous route, in the right upper posterior deltoid region (lot # reported as L036823 with expiration date 24-DEC-2016) in the same vaccination session. No concomitant medications were reported. The patient did not report any adverse effects. No product quality complaint was involved. Additional information has been requested.
This case was reported by a nurse and described the occurrence of fever in a 26 year old male pt who received hep B vaccine recombinant (Engerix B) for prophylaxis. The pt had no relevant medical history, concurrent conditions, or concurrent medications. He reported that he developed a fever of 103 deg F and passed out following receipt of influenza virus vaccine. On 6/24/03 at 7:30, the pt received Engerix B (373B6). On 6/24/03 at 8:30, one hour post immunization, the pt telephoned the nurse and reported that he had a fever of 101.6 deg F and was experiencing itching and hives. He stated that he also felt dizzy and had a headache. At that time, he "realized" that he had received the hep B immunization series in 2002 "without any problems." The pt was treated with 50mg of oral Benadryl. The pt then began to shake. As of 12:50 on 6/24/03, the hives had resolved, but the other events persisted. The nurse considered the events were probably related to vaccination with Engerix B.
Breakthrough case admission after 3 vaccines Pfizer 2/3/21 Lot# EL9269;  Pfizer 2/24/21 Lot# En6202;  Pfizer 9/29/21 Lot# 301308A
Redness/itching @ inject site, local erythema, h/a, & rash w/fever of 101, 24 hrs p/vax administration; sx lasted 2 days; local reaction still being treated w/DPH & ice;
Burning sensation on both arms; Headache; Heart beat went faster; Burning sensation when they put the needle in; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Burning sensation on both arms), HEART RATE INCREASED (Heart beat went faster), INJECTION SITE PAIN (Burning sensation when they put the needle in), PYREXIA (Fever) and CHILLS (Chills) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (was pretty sick and took 2 weeks to recover) from 01-Dec-2020 to December 2020.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HEART RATE INCREASED (Heart beat went faster), INJECTION SITE PAIN (Burning sensation when they put the needle in), PYREXIA (Fever) and CHILLS (Chills). On 24-Jan-2021, the patient experienced SKIN BURNING SENSATION (Burning sensation on both arms) and HEADACHE (Headache). On 26-Jan-2021, SKIN BURNING SENSATION (Burning sensation on both arms), HEART RATE INCREASED (Heart beat went faster), INJECTION SITE PAIN (Burning sensation when they put the needle in), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Student received injections on 5-24-10 without complications. On 5-26-10 student presented to school nurse with a 3" reddened area on (R) deltoid with mild tenderness and warmth. Mother phoned HD on 5-26-10 at 10:00 am to inform mother instructed to talk  to Dr. for examination. Follow-up phone call made to mother, on 5-26-10 at 1:00pm. Mother called patient's Dr in am; was instructed to measure area apply ice and call back if area increases in size. Patient remaining in school today.
large area of redness & swelling to lt thigh @ inj site whole thigh area involved;no inc temp attempted to contact x3 for f/u;
About 1 hr after receiving vaccine, presented back in office w/hives on face, red blotchy spot on right side of face, another slightly raised spot on chin. Small red spot under left eye. Some fading already, gave BENADRYL.
Went to the dentist on 4/17/21 for routine cleaning.  My gums became sore the next day.  Today is 4/21, 4 days later and my gums are still sore.  Normal gum soreness for me after a cleaning goes away by the next day when I wake up.    On Sunday 4/18, I was working on the car and bruised my arm/wrist in a couple of places.  That evening the locations bruised up really good and was tender.  Today the areas are still tender and have dark bruising patterns.   I generally do not bruise like this, and frankly was surprised bruises even appeared.   Yes, I did bang my arm on the car a couple of times, but no where hard enough to receive this kind of bruising.  I do not think this is an issue for me -- more of "just dealing with the inconvenience," but am curious if this is some sort of side effect from the vaccine.  I could not find any information online related to "easily bruises" at all.
At about 3 pm the day of vaccination, patient began to cough in response to a tickling sensation in throat.  The cough got progressively worse ove the enxt 2 hours in response to what felt like a "river" of drainage.  Patient took Nyquil Cough to sleep & felt better the next am.
Patient received 1st dose Covid 19 vaccine Moderna 3/5/2021 lot # 042L20A at facility Patient received 2nd dose Covid 19 vaccine Moderna 4/2/2021 lot # 042L20A at facility Patient received 3rd dose Covid 19 vaccine Pfizer 4/26/2021 lot # EW0169 at facility Patient received 4th  dose Covid 19 vaccine Pfizer 1/8/2022 lot #33025BD at facility
DIED; This spontaneous report received from a consumer via social media concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  Reporter stated that "My mother received a vax and was dead the next morning". On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20220152346 -JANSSEN COVID-19 VACCINE Ad26.COV2.S- DIED. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Had to stay in bed all day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Had to stay in bed all day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ASTHENIA (Had to stay in bed all day). On 26-Feb-2021, ASTHENIA (Had to stay in bed all day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
reddness at injection site; pain at injection site; underdose; accidental exposure to vaccine; drop leaked out on to patients arm; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number AC79X, expiry date 17th October 2021) for prophylaxis.   On 5th July 2019, the patient received Shingrix .45 ml. On 5th July 2019, unknown after receiving Shingrix, the patient experienced accidental underdose, inadvertent exposure to vaccine and exposure via skin contact. On 11th July 2019, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site pain, accidental underdose, inadvertent exposure to vaccine and exposure via skin contact were unknown.   It was unknown if the reporter considered the injection site erythema and injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporter stated that during administration a drop leaked out on to patients arm which led to accidental underdose, inadvertent exposure to vaccine and exposure via skin contact. The reporter stated that, the patient received 0.45 ml dose. The patient at the time of reporting was presented with redness and pain at injection site.
Insomnia; Wide awake in the middle of the night; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 14May2021 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunization. Medical history included no other health issues. Patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 23:00, the patient had insomnia which was really frustrating. She would be wide awake in the middle of the night and it had been 10 days already. The patient never ever had issues sleeping and she experienced this only after taking 2nd shot. The events result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken and included treatment with melatonin 1mg (MANUFACTURER UNKNOWN) medication which didn't help much in falling asleep. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event insomnia and will be wide awake in the middle of the night was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Localized erythema - mom described as the size of a baseball tx with BENADRYL
Feel like I'm experiencing myocarditis, it felt like a sore muscle in my chest, and gradually went from one pulse of pain to a mild constant pain, about a 2 on a scale of 1-10
Had sore arm the same day. The next day had blood sugar over 300 off and on for the next 2 days. Normal levels around 100-240. The blood sugar settled by 3rd day. On 3rd day, the abdominal bloating began; looked like if 6 months pregnant. Bloating was frequent and lasted for about 10 days. Also had nausea, on and off combined with the bloating. Took Tums a few times but did not help much. Had chills did not take temp to check whether had fever. Had not flashes/flushed. On and off mild headache. Feeling better by this Monday, feeling fine now.  The worst part of the ordeal was the bloating. Went to cancer doctor and told him about symptoms since had appointment. Pt was worried because of the other medical conditions she had. In the center they only use the regular flu vas so pt was not sure whether had the right one.
Within 10 mins still in the doctor's office he started to feel pains in his joints. When he went to get up he felt very weak. He informed nurse and she made him sit down and while sitting he had a throbbing pain in his lower back.  After a while it subsided and went away.
C/O Anxiety, feeling faint, trouble breathing, chest pressure she C/O feeling faint and was brought to cot to lay down, then C/O trouble breathing, Vital signs were monitored and EMS was called. She was transported by EMS to hospital
Sore throat and cough about four hours after. Slept poorly. Facial swelling next morning. Took a BENADRYL and felt much better in about a half hour.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 13-AUG-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Patient experienced redness and swelling that took up half of her arm. She also states the site has been itchy.